Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Adverse Event Reports: Posting On ClinicalTrials.gov Begins Soon

This article was originally published in The Gray Sheet

Executive Summary

Device and drug firms must begin posting serious and frequent adverse event data from certain clinical trials on the National Institutes of Health's ClinicalTrials.gov database by September, NIH confirmed April 20
Advertisement

Related Content

ClinicalTrials.gov: NIH Busy Educating Sponsors On Mandates While Regs Remain In The Works
ClinicalTrials.gov: NIH Busy Educating Sponsors On Mandates While Regs Remain In The Works
Regs Or No Regs, FDA Will Seek Adherence To ClinicalTrials.gov Mandates
Regs Or No Regs, FDA Will Seek Adherence To ClinicalTrials.gov Mandates
Regulatory News In Brief
Regulatory News In Brief
Unapproved Product Trial Data: To Post Or Not To Post On ClinicalTrials.gov?
Final Guidance Names Submissions Subject To ClinicalTrials.gov Certification
Final Guidance Names Submissions Subject To ClinicalTrials.gov Certification
House Adds Device Adverse Events To Trial Registry Requirements

Topics

Advertisement
UsernamePublicRestriction

Register

MT027356

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel